that excises the hemorrhoids spinal or local anesthesia leaving raw areas in anal canal [8] . Although this would be considered as the gold standard for the operative treatment of hemorrhoids, patients often experience notable postoperative pain which can impact on patient function for weeks following surgery. Due to the difficult postoperative recovery of this procedure, alternative techniques for performing hemorrhoidectomy have been explored [9] . Unlike specialized surgical devices, lasers are widely available in the operating theatre and are used in many operations to cauterise tissue. Consequently, lasers have been used to treat hemorrhoids with the expectation of reducing post operative pain [10] . Although the laser appears to offer some advantages in open hemorrhoidal surgical procedures, some randomized trials comparing the use of lasers versus open hemorrhoidectomy have shown no significant differences in post operative pain and other complications [11] .
In the present study, we compared the efficacy and complications between intrahemorrhoidal coagulation with 980 nanometer diode laser versus Milligan Morgan hemorrhoidectomy.
Methods
In a prospective clinical trial and after approval from the Ethics Committee at the Tehran University of Medical Sciences and obtaining written informed consent from the participants, 60 consecutive adult patients of American Society of Anesthesiologists (ASA) physical status I-II, age more than 18 years with symptomatic internal hemorrhoid disease third to fourth degree and non-respond to medical treatment, scheduled for hemorrhoidectomy surgery between January 2010 and 2011 were included in this randomized double-blind placebo controlled trial. Exclusion criteria were huge or prolapsed hemorrhoids, substance use, anorectic problems such as concurrent fisher, cardiovascular disease, hepatic disease or kidney injury, or history of drug sensitivity. The patients were randomly allocated by drawing blocked randomization to undergo either Milligan-Morgan hemorrhoidectomy (n=30) or intrahemorrhoidal coagulation with 980 nanometer diode laser (n=30). At surgery room and after setting ECG monitoring and pulse oxymetry, intravenous line was secured with 18G i.v canula and ringer lactate infusion (5cc/kg) was started. All patients were uniformly premedicated with Midazolam 1.0 mg, and then anesthesia was induced with sodium thiopental (5 mg/kg) and Sufentanil (0.1 µg/kg). For maintaining anesthesia, N2O 50% and isoflurane 0.5% to 1.5% were used. All patients received Sufentanil 5mg and Atracurium 10 mg (0.5 mg/kg) every 30 minutes.
All participants in lithotomy position underwent anoscopy and hemorrhoid pockets were determined.
The patients in Milligan-Morgan hemorrhoidectomy operated on using a standard open hemorrhoidectomy technique [12] . In laser method, hemorrhoid pockets were coagulated in parallel and with 5 mm intervals with radial laser fibers 980 nm, the laser power 15 watt and 3 seconds pulses. At the end of the operation, neostigmine (40µg/kg) and atropine (20µg/kg) were intravenously injected for antagonizing residual neuromuscular blockade. Blood pressure, pulse rate, and arterial oxygen saturation were monitored and recorded intraoperatively and every 5 minutes. At recovery room, patients were connected to a Patient-controlled analgesia (PCA) system including morphine sulfate (30 mg) at normal saline (30 ml). In any cases with pain, morphine 1 mg was injected with an 8-minute lock out time. After the operations, the patients were transferred to the wards. Pain was assessed every 6 hours within 24 hour after the procedures using a visual analog scale (VAS) in which 0 corresponds to "no pain" and 10 to "maximum pain" [13] . Postoperative complications and event including Intraoperative and postoperative bleeding, Urinary retention, wound infection, postoperative hospital stay, and Consumed morphine dose based on the PCA recording were assessed. Regressed hemorrhoid pockets were also recorded as complete or partial regression. The main criteria for discharge of the patients were: tolerating food, appropriate control of pain, and absence of bleeding. A follow-up examination was performed 1 week, as well as 1, 3, and 6 months postoperatively to assess improvement in clinical signs.
Results were presented as mean ± standard deviation (SD) for quantitative variables and were summarized by absolute frequencies and percentages for categorical variables. Categorical variables were compared using chi-square test or Fisher's exact test when more than 20% of cells with expected count of less than 5 were observed. Quantitative variables were also compared t test or Mann-Whitney U test. Multivariable linear regression analysis was used to determine differences in pain severity and bleeding between the two therapeutic procedures. Statistical significance was determined as a p value of ≥ 0.05. All statistical analysis was performed using SPSS software (version 16.0, SPSS Inc., Chicago, Illinois).
Results
In this study, totally 60 patients (30 patients who underwent Milligan-Morgan hemorrhoidectomy (mean age 47.2 ± 14.0 years, 40.0% male), and 30 patients who underwent intrahemorrhoidal coagulation with 980 nanometer diode laser (mean age 43.3 ± 13.8 years, 65.5% male) were evaluated. One of the patients were excluded from the laser group because of the lost to followup. The two groups were significantly comparable in terms of gender ratio and age. Also, both groups were matched for the number of packets. With respect to the postoperative pain severity based on VAS score within 24 hours after the operation (Table 1 & Figure 1 ), although pain severity during first 6 hours was nonsignificantly higher in the diode laser group, but pain severity was significantly more decrease in this group compared with the surgical hemorrhoidectomy group. This significance was also confirmed by the repeated measured ANOVA test (p < 0.001). Both intraoperative and postoperative bleeding was more severe in the Milligan-Morgan hemorrhoidectomy group ( Table 2 ). The time of operation was significantly higher in Milligan-Morgan hemorrhoidectomy group than laser group (52.3±15.1 min versus 32.8±7.0 min, p < 0.001). Also, hospital stay was longer in Milligan-Morgan hemorrhoidectomy group as well as the dose of consumed morphine after the procedure was significantly lower in those who treated with coagulation with 980 nanometer diode laser. None of the study groups experienced postoperative local infection. Two patients in the laser group experienced thrombosis 3 to 4 days after the surgery that both were medically treated. The mean discharge analgesic for laser and MilliganMorgan hemorrhoidectomy groups was 5.4 ± 1.9 and 7.0 ± 2.2, respectively (p = 0.002). The two groups were not different in terms of the prevalence of postoperative urinary retention, the number of regressed hemorrhoidal pockets, and also improvement of clinical signs within six months follow-up time (Table 3) . According to the multivariable linear regression analysis (Table 4) , postoperative pain severity was significantly lower in the patients treated with intrahemorrhoidal coagulation with 980 nanometer diode laser than another technique. Also, this analysis showed that the patients who underwent former therapeutic technique experienced less intraoperative and postoperative bleedings when adjusted for gender and age.
Disussion
Our study findings were particularly based on the superiority of the use of intrahemorrhoidal coagulation with 980 nanometer diode laser in comparison with Milligan-Morgan hemorrhoidectomy in patients with symptomatic hemorrhoid non-responded to medical treatment. This more effectiveness was observed in terms of pain severity, severity of intraoperative and postoperative bleeding, length of postoperative hospital stay, and dosage of consumed morphine for pain relief. However, no difference was revealed regarding prevalence of urinary retention, postoperative wound infection, regression of hemorrhoidal pockets, and improvement of clinical signs of hemorrhoid 6 months after the operation.
Although in previous studies, the benefits of laser therapy was proved compared to other classic surgical treatments, our study seems to be unique because effectiveness of intrahemorrhoidal coagulation with 980 nanometer diode laser technique was evaluated for the first time and also compared with other techniques. Then laser is as effective as conventional surgery in the mid-term because of the efficacy of laser therapy symptoms relieved within 6 month follow up. According to this fact that in laser therapy compared with surgical treatments, postoperative pain severity and bleeding were less prevalent and the procedure was performed using sedation and local anesthetic, patients' satisfaction is predictable. Moreover, because of local anesthesia, the complications of general anesthesia will be not appeared and thus the superiority of laser therapy will be warranted. Therefore, although we did not assess, the patients' satisfaction as well as their improved quality of life following laser therapy can be predicted. However, our study had some limitations. First, although our study was performed on a greater sample in comparison with the previous studies, but according to no occurrence of death and wound infection, evaluation of the efficacy of intrahemorrhoidal coagulation with 980 nanometer diode laser with regard to these phenomena was not possible. In addition, follow-up time in our study was relatively short and therefore we could not assess long- term clinical improvement. In this context, further studies using greater size and with long-term following-up is recommended.
In conclusion, intrahemorrhoidal coagulation with 980 nanometer diode laser compared to Milligan-Morgan hemorrhoidectomy is more recommended because of its lower postoperative pain severity, less intraoperative and postoperative bleeding, shorter hospital stay, and no needed to high dosages of analgesics and sedatives.
